Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C →T polymorphism

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

Theme Issue
European Vascular Biology Meeting 2011 (Part 1)

Issue: 2012: 108/3 (Sep) pp. 405-588
Pages: 533-542

Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C →T polymorphism

Online Supplementary Material

A. Dragani (1), A. Falco (2), F. Santilli (2), S. Basili (3), G. Rolandi (1), L. Cerasa (2), S. Lattanzio (2), G. Ciabattoni (2), C. Patrono (4), G. Davì (2)

(1) Departments of Haematology and Laboratory Medicine, Civil Hospital Pescara, Italy; (2) ”G. d’Annunzio” University Foundation and Department of Drug Sciences, University of Chieti “G. d’Annunzio” Schools of Medicine and Pharmacy, Chieti, Italy; (3) Department of Medicine, “La Sapienza”, University of Rome, Rome, Italy; (4) Department of Pharmacology, Catholic University School of Medicine, Rome, Italy


hyperhomocysteinaemia, oxidative stress, platelet activation, folate supplementation, MTHFR 677 C→T polymorphism


The methylenetetrahydrofolate reductase (MTHFR) 677 C→T polymorphism may be associated with elevated total homocysteine (tHcy) levels, an independent risk factor for cardiovascular disease. It was the study objective to evaluate in vivo lipid peroxidation and platelet activation in carriers of the MTHFR 677 C→T polymorphism and in non-carriers, in relation to tHcy and folate levels. A cross-sectional comparison of urinary 8-iso-prostaglandin (PG)F2α and 11-dehydro-thromboxane (TX)B2 (markers of in vivo lipid peroxidation and platelet activation, respectively) was performed in 100 carriers and 100 non-carriers of the polymorphism. A methionine-loading test and folic acid supplementation were performed to investigate the causal relationship of the observed associations. Urinary 8-iso-PGF2α and 11-dehydro-TXB2 were higher in carriers with hyperhomocysteinaemia than in those without hyperhomocysteinaemia (p<0.0001). Hyperhomocysteinaemic carriers had lower folate levels (p=0.0006), higher urinary 8-iso-PGF2α (p<0.0001) and 11-dehydro-TXB2 (p<0.0001) than hyperhomocysteinaemic non-carriers. On multiple regression analysis, high tHcy (p<0.0001), low folate (p<0.04) and MTHFR 677 C→T polymorphism (p<0.001) independently predicted high rates of 8-iso-PGF2α excretion. Methionine loading increased plasma tHcy (p=0.002), and both urinary prostanoid metabolites (p=0.002). Folic acid supplementation was associated with decreased urinary 8-iso-PGF2α and 11-dehydro-TXB2 excretion (p<0.0003) in the hyperhomocysteinaemic group, but not in the control group, with substantial inter-individual variability related to baseline tHcy level and the extent of its reduction. In conclusion, hyperhomocysteinaemia due to the MTHFR 677 C→T polymorphism is associated with enhanced in vivo lipid peroxidation and platelet activation that are reversible, at least in part, following folic acid supplementation. An integrated biomarker approach may help identifying appropriate candidates for effective folate supplementation.

You may also be interested in...


F. Santilli (1), R. Liani (1), P. Di Fulvio (1), G. Formoso (1), P. Simeone (1), R. Tripaldi (1), T. Ueland (2), P. Aukrust (2), G. Davì (1)

Thromb Haemost 2016 116 6: 1089-1099


Online Supplementary Material

F. Santilli (1), N. Vazzana (1), P. Iodice (2), S. Lattanzio (1), R. Liani (1), R. G. Bellomo (3), G. Lessiani (1), F. Perego (4), R. Saggini (2), G. Davì (1)

Thromb Haemost 2013 110 6: 1232-1240

St. Engeli

Adipositas 2007 1 2: 74-78